Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

Foreign CMOs expand US capacity as pharma supply chains regionalize, reveals GlobalData

Foreign contract manufacturing organizations (CMOs) are accelerating investment in US manufacturing as pharmaceutical companies prioritize supply-chain resilience, regional capacity and greater control over production. The recent site upgrades, acquisitions and new partnerships signal a shift from cost-driven outsourcing toward integrated, locally anchored models, giving sponsors broader access to end-to-end capabilities while reducing exposure to geopolitical, […]
Read more

India card payments to rise steadily as financial inclusion deepens and credit cards gain traction, says GlobalData

India’s payment card usage is set to gradually rise over the coming years. This upward trend is firmly underpinned by a steadily growing banked population across the country. Furthermore, the improving payments infrastructure and consumers’ increasing preference for electronic payments over traditional cash transactions are heavily driving this significant shift toward a completely digital economy, […]
Read more

Apple China hiring signals AI push, says GlobalData

Apple is deepening its technology and operational capabilities in China, with recent hiring spanning artificial intelligence (AI) and machine learning alongside data infrastructure, supply chain, privacy and export compliance. The breadth of recruitment signals a strategic shift toward building a more integrated technology ecosystem, reinforcing China’s role in Apple’s innovation, operations and regional business strategy, […]
Read more

Harvey Nichols can bounce back under Frasers Group, says GlobalData

The contrasting fortunes of Harrods, Harvey Nichols, Fenwick and John Lewis & Partners highlights how sharply the UK department store channel is diverging. While Harrods has returned to profit, Fenwick is showing early signs of a turnaround and John Lewis & Partners is undergoing a strategic reset under new leadership. Harvey Nichols, by contrast, is […]
Read more

UK VC funding value soars 113% YoY despite flat deal activity during January–July 2026, finds GlobalData

The UK’s venture capital (VC) ecosystem demonstrated remarkable resilience during the first seven months (January–July) of 2026, recording a more than two-fold (113%) expansion year-on-year (YoY) in total capital deployed despite stagnant deal volume, reveals GlobalData, a leading intelligence and productivity platform. Aurojyoti Bose, Lead Analyst at GlobalData, comments: “The trend suggests a pronounced shift […]
Read more

Daraxonrasib approval changes standard of care in second-line pancreatic cancer, says GlobalData

The US FDA approval of Revolution Medicine’s Rasonque (daraxonrasib) changes the standard of care in second-line pancreatic cancer, as the oral therapy will displace the intensive and complicated-to-administer chemotherapy regimens currently used in practice, revealsGlobalData, a leading intelligence and productivity platform. Israel Stern, Healthcare Senior Analyst at GlobalData, comments. “Unlike first-generation RAS inhibitors, that only bind […]
Read more

APAC deal activity down 11% YoY in first seven months of 2026, reveals GlobalData

The total number of deals (mergers & acquisitions (M&A), private equity and venture capital (VC)) announced across the Asia-Pacific (APAC) region year-on-year (YoY) decreased by around 11% during January–July 2026, reflecting a broad-based cooling in deal-making appetite, reveals GlobalData, a leading intelligence and productivity platform. Aurojyoti Bose, Lead Analyst at GlobalData, comments: “The overall contraction […]
Read more

Moderna’s melanoma vaccine sales forecast to surpass $1 billion by 2031 following landmark Phase III win, forecasts GlobalData

Sales of Moderna and Merck’s personalized cancer vaccine intismeran autogene are projected to surpass $1 billion by 2031, following positive Phase III INTerpath-001 results in high-risk resected melanoma, reveals GlobalData, a leading intelligence and productivity platform . Intismeran autogene, given alongside Merck’s Keytruda (pembrolizumab), met its primary endpoint of statistically significant recurrence-free survival and its […]
Read more

European wildfires expose mounting pressure on insurers as climate risks intensify, says GlobalData

European insurers face mounting losses as severe wildfires sweep across France, Spain and Greece, exposing the narrow margins in high-risk property coverage. France’s 2024 fire and hazard insurance data show how quickly claims can approach premiums, raising concerns over insurers’ capacity to absorb escalating climate-related losses and maintain coverage in increasingly vulnerable regions, reveals GlobalData, […]
Read more

Australia’s AIM-260 purchase and first sovereign rocket test signal shift toward missile supply resilience, says GlobalData

Australia’s decision to acquire Lockheed Martin’s AIM-260 Joint Advanced Tactical Missile alongside the first flight test of a sovereign solid rocket motor signals a broader shift in missile strategy: securing advanced capability today while building the industrial capacity to sustain it tomorrow. With missile demand outpacing Western production, the twin moves strengthen Australia’s long-term deterrence […]
Read more

Human–AI collaboration hiring accelerates as industries redesign work for agentic AI, reveals GlobalData

Workforce strategies are increasingly integrating artificial intelligence (AI) across industries. A recent analysis of hiring trends reveals that jobs referencing human-AI continued to grow in the second quarter (Q2) of 2026, underscoring the transformative impact of agentic AI on traditional business models, reveals the Job Analytics Database of GlobalData, a leading intelligence and productivity platform. […]
Read more

Type 2 diabetes across 7MM faces growing comorbidity burden amid rising obesity and aging, reveals GlobalData

Type 2 diabetes is carrying a growing burden of comorbidities across the seven major markets (7MM*), with hypertension emerging as the most prevalent diagnosed condition among patients with the disease. Higher BMI, sedentary lifestyles, poor diets, and aging populations are intensifying this burden, highlighting the need for more comprehensive disease management and prevention strategies, according […]
Read more

Long-acting therapies continue to gain momentum in HIV, says GlobalData

The next phase of competition in the HIV market will be defined not only by achieving viral suppression, but by improving treatment adherence, reducing medication burden and delivering more convenient treatment options, with long-acting therapies at the forefront, according to GlobalData, a leading intelligence and productivity platform. GlobalData forecasts that the HIV market across the […]
Read more

2026 FIFA World Cup sets new benchmark for sports ticketing revenue, reveals GlobalData

The 2026 FIFA World Cup shattered tournament attendance records, underscoring the extraordinary commercial pull of soccer across North America. With 89% of matches achieving at least 99% capacity and 69% selling out, FIFA’s ticketing strategy has delivered significant revenue gains, while potentially setting a new benchmark for pricing major sporting events, reveals GlobalData, a leading […]
Read more

India’s enterprise ICT revenue to grow at 15.5% CAGR through 2030, forecasts GlobalData

India’s enterprise information and communications technology (ICT) market is set to expand at a compound annual growth rate (CAGR) of 15.5% through 2030, as surging artificial intelligence (AI) adoption, cloud transformation, data center investment and digital infrastructure reshape technology spending. The scale and pace of growth signal a decisive shift toward AI-ready, cloud-enabled enterprise ecosystems, […]
Read more
1 2 3 … 206